Baldasare Bryan T 4
4 · MERIDIAN BIOSCIENCE INC · Filed Feb 8, 2021
Insider Transaction Report
Form 4
Baldasare Bryan T
Chief Accounting Officer
Transactions
- Sale
Common Stock
2021-02-05$26.61/sh−14,250$379,126→ 58,632 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-02-05−11,250→ 3,750 totalExercise: $19.56Exp: 2026-03-24→ Common Stock (11,250 underlying) - Exercise/Conversion
Common Stock
2021-02-05$19.56/sh+11,250$220,050→ 72,882 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
- [F2]Prices range from $25.00 per share to $29.00 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
- [F3]The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
- [F4]These non-qualified options were awarded under the 2012 Stock Incentive Plan and vested in four equal installments from the date of grant and were fully vested on March 24, 2020.